10 Stocks Insiders Are Buying In March

2. Evolent Health, Inc. (NYSE:EVH)

Number of Insiders Buying: 9

Market Capitalization: $1.08 billion

Evolent offers healthcare plans and benefits management services. The Arlington, Virginia-headquartered company provides an integrated platform for health plan administration and value-based business infrastructure, and administrative services.

For the full 2024, the company reported revenue of $2.55 billion, compared to $1.96 billion in 2023. Net loss amounted to $93.45 million, an improvement from $142.26 million in the prior year. For 2025, Evolent expects revenue in the range of approximately $2.06 billion to $2.11 billion. The company noted that its revenue guidance represents a projection of 15%-18% annual growth after adjusting for one-time contract changes in three Performance Suite contracts moving from 2024 to 2025. Adjusted EBITDA is expected to be in the range of approximately $135 million to $165 million.

In March, nine insiders, among which is the company’s CEO, bought a total of $1.25 million worth of Evolent shares at an average price of $9.10 per share. Currently, the stock is trading at $9.54, having declined 15.20% since the beginning of the year, or 71.51% over the past 12 months.

Fifteen analysts have given an average “Strong Buy” rating on Evolent stock with a price target of $15.77, according to TipRanks.